US 12097261
CDK2 degraders and uses thereof
granted A61KA61K47/55A61P
Quick answer
US patent 12097261 (CDK2 degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K47/55, A61P, A61P35/00